ISI's Health Care Research Team, headed by Mark Schoenebaum, focuses on providing actionable investment ideas and proprietary research on Biotechnology, Pharmaceutical, and Specialty Pharmaceutical stocks.

Mark has been conducting research on biotechnology  companies for more than 10 years. Mark and his team provide clients with an investment edge through “data tidbits” and "on-the-fly" analysis in response to breaking news.  They also provide "deep-dive" analyses on clinical, financial, and market data.

The Health Care Research Team is available around the clock, conducts customized client projects, assists with corporate access, and accepts personal meetings.

Sample Health Care Research Report: Biotechnology